The page is the record's research on the issuer — no analyst, no rating, no view.

LEADS BIOLABS-B (09887) — research page

HK · hk-cm-kg/HKEX/09887 · as of 2026-11-04

Identity and listing

The issuer is LEADS BIOLABS-B, listed on the Main Board of HKEX under ticker 09887, with ISIN CNE1000070H8. The LEI is not on the record, because the ISIN is not in the GLEIF mapping file on this node. Its security type is Corporate, its segment and sector are not on the record, and its jurisdiction is not on the record because there is no LEI record. Its listing status is listed, not halted.

fieldvaluesource · read date
nameLEADS BIOLABS-Bsource · 2026-11-04
exchangeMain Boardsource · 2026-11-04
ticker09887source · 2026-11-04
ISINCNE1000070H8source · 2026-11-04
LEInot on the record
security typeCorporatesource · 2026-11-04
segmentnot on the record
sectornot on the record
jurisdictionnot on the record
statuslisted, not haltedsource · 2026-11-04

The disclosure read

The record holds 88 filings across 66 filing days in the window from 2025-11-04 to 2026-11-04. The median gap between filing days is 4 days. The latest filing is dated 2026-11-03, and it is a monthly return, 1 day before the record date of 2026-11-04. The Main Board median cadence gap is 9.0 days across 2,472 issuers, with a median of 46.0 filings and a median latency of 2.0 days. The issuer's 88 filings are above the Main Board median of 46.0 filings. The sector peer median is not on the record.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer8841
exchange median: Main Board (2472 issuers)4692
datetypecategoryfiling
2026-11-03monthly_returnMonthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
2026-10-30announcementVOLUNTARY ANNOUNCEMENT PART B OF LBL-047 PHASE I STUDY COMPLETES FIRST DOSING OF A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS; NOVEL BDCA2/TACI DUAL-TARGETING DESIGN ENTERS CLINICAL EVALUATION IN PATIENTS
2026-10-26announcementVOLUNTARY ANNOUNCEMENT PRESENTATION OF UPDATED CLINICAL AND TRANSLATIONAL DATA OF LBL-024 FOR EXTRAPULMONARY NEUROENDOCRINE CARCINOMA, BILIARY TRACT CANCER AND COLORECTAL CANCER AT 2026 ESMO
2026-10-25announcementVOLUNTARY ANNOUNCEMENT ORAL PRESENTATION OF UPDATED CLINICAL DATA OF LBL-034 FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA AT 2026 ESMO
2026-10-20announcementVOLUNTARY ANNOUNCEMENT PHASE II STUDY OF LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) AS FIRST-LINE TREATMENT FOR GASTRIC CANCER PROGRESSES TO EXPANSION STAGE

window 2025-11-04 to 2026-11-04 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is Ernst & Young. Its location is not on the record. Auditor changes are not on the record, because this register has no lifecycle type map yet.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, because this register has no lifecycle type map yet. The issuer is listed, not halted.

Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/hk/suitability-sfc-code-of-conduct-paragraph-5-2/r1, with chapter as of 2026-11-04.

rule acm-68000/hk/suitability-sfc-code-of-conduct-paragraph-5-2/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's own investor-relations page, so the count is 0.

Open research

No openly published research notes were found, so the count is 0.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The issuer's years are not sealed in the served record, and the market's vintage is not sealed. The live record began on 2026-09-12. The years 2021 through 2026 are sealed in the store but are not served as of a date, and the as-of door answers not_sealed.

Sources

6 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.hkex.com.hk/eng/services/trading/securities/securitieslists/ListOfSecurities.xlsx (identity.exchange)
10.2
https://mcp.hk-cm-kg.ai/events/HKEX/09887 (the disclosure lines)
10.3
https://www.hkex.com.hk/eng/stat/smstat/dayquot/d261104e.htm (the halt flag)
10.4
https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0424/2026042403304.pdf (the auditor)
10.5
https://mcp.hk-cm-kg.ai/book/aio.json (the orderability chapter)
10.6
https://mcp.hk-cm-kg.ai/record/HKEX/09887 (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"CNE1000070H8"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:9937dca86c33df91.